← Product Code [HAW](/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/HAW) · K043088 # MEDTRONIC SNT STEALTHSTATION AXIEM IMAGELESS KNEE MODULE (K043088) _Medtronic Surgical Navigation Technologies · HAW · Jan 5, 2005 · Neurology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/HAW/K043088 ## Device Facts - **Applicant:** Medtronic Surgical Navigation Technologies - **Product Code:** [HAW](/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/HAW.md) - **Decision Date:** Jan 5, 2005 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 882.4560 - **Device Class:** Class 2 - **Review Panel:** Neurology - **Attributes:** Pediatric ## Indications for Use The StealthStation® System is intended as an aid for precisely locating anatomical structures in either open or percutaneous procedures. The StealthStation® System is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT or MR based model, fluoroscopy images, or digitized landmarks of the anatomy. Example procedures include, but are not limited to: Cranial Procedures: Cranial Biopsies, Tumor Resections, Craniotomies/ Craniectomies, Skull Base procedures, Thalamotomies/Pallidotomies, Pituitary Tumor Removal, CSF Leak Repair, Pediatric Catheter Shunt Placement, General Catheter Shunt Placement. Spinal Procedures: Spinal Implant Procedures, such as Pedicle Screw Placement. ENT Procedures: Transphenoidal Procedures, Intranasal Procedures, Orbital Nerve Decompression Procedures, Optic Nerve Decompression Procedures, Polyposis Procedures, Endoscopic Dacryocystorhinostomy, Encephalocele Procedures, Sinus procedures, such as Maxillary Antrostomies, Ethmoidectomies, Sphenoidotomies/Sphenoid Explorations, Turbinate Resections, and Frontal Sinusotomies. Orthopaedic Procedures: Total Knee Arthroplasty (Primary and Revision), Unicompartmental Knee Arthroplasty, Minimally Invasive Orthopaedic Knee Procedures. ## Device Story StealthStation AxiEM Imageless Knee Module provides surgical navigation for orthopaedic knee procedures. System utilizes electromagnetic (EM) tracking technology to locate anatomical structures without pre-operative imaging. Input consists of digitized anatomical landmarks; system processes spatial data to provide real-time navigation. Used in OR by surgeons to guide instrumentation during knee arthroplasty. Output displayed to surgeon to assist in precise positioning of implants. Benefits include improved surgical accuracy and potential for minimally invasive approaches. ## Clinical Evidence Bench testing only; no clinical data provided. Verification and validation activities performed to demonstrate substantial equivalence. ## Technological Characteristics Electromagnetic (EM) tracking system; imageless navigation; integrates with StealthStation platform; software-based spatial localization; intended for use with rigid anatomical structures. ## Regulatory Identification A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system. ## Predicate Devices - Imageless Hip Module - GoldenEye Micro-Magnetic Tracking System Option ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} Ko43088 1/2 JAN - 5 2005 Medtronic (SNT) StealthStation AxiEM™ Imageless Knee Module Summary of Safety and Effectiveness Medtronic (SNT) StealthStation AxiEM™ Imageless Knee Module I. Manufacturer Medtronic Surgical Navigation Technologies 826 Coal Creek Circle Louisville, Colorado 80027 USA Telephone Number: (720) 890-3217 Fax Number: (720) 890-3517 II. Contact Tina Dreiling Associate Regulatory Affairs Specialist Medtronic Surgical Navigation Technologies III. Product Name / Classification Product Name: Medtronic (SNT) StealthStation AxiEM™ Imageless Knee Module Classification Name: Stereotaxic Instrument (21 CFR 882.4560) Classification Panel: 84 HAW IV. Date Summary Submitted December 13, 2004 V. Description of Device Modification This submission describes updates made to the Imageless Knee Module for the StealthStation to enable this application to be used in conjunction with the AxiEM™ electromagnetic navigation technology. VI. Substantial Equivalence The Medtronic (SNT) StealthStation AxiEM™ Imageless Knee Module is shown to be substantially equivalent to the Imageless Hip Module and the GoldenEye Micro-Magnetic Tracking System Option cleared in previous 510(k)s. As required by risk analysis, all verification and validation activities performed by designated individuals and the results demonstrated substantial equivalence. Medtronic Surgical Navigation Technologies {1} K043088 2/2 # Medtronic (SNT) StealthStation AxiEM™ Imageless Knee Module ## VII. Indications for Use The indications for use are as follows: The StealthStation® System is intended as an aid for precisely locating anatomical structures in either open or percutaneous procedures. The StealthStation® System is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT or MR based model, fluoroscopy images, or digitized landmarks of the anatomy. Example procedures include, but are not limited to: ### Cranial Procedures: - Cranial Biopsies - Tumor Resections - Craniotomies/ Craniectomies - Skull Base procedures - Thalamotomies/Pallidotomies - Pituitary Tumor Removal - CSF Leak Repair - Pediatric Catheter Shunt Placement - General Catheter Shunt Placement ### Spinal Procedures: Spinal Implant Procedures, such as Pedicle Screw Placement ### ENT Procedures: - Transphenoidal Procedures - Intranasal Procedures - Orbital Nerve Decompression Procedures - Optic Nerve Decompression Procedures - Polyposis Procedures - Endoscopic Dacryocystorhinostomy - Encephalocele Procedures - Sinus procedures, such as Maxillary Antrostomies, Ethmoidectomies, Sphenoidotomies/Sphenoid Explorations, Turbinate Resections, and Frontal Sinusotomies ### Orthopaedic Procedures: - Total Knee Arthroplasty (Primary and Revision) - Unicompartmental Knee Arthroplasty - Minimally Invasive Orthopaedic Knee Procedures Medtronic Surgical Navigation Technologies {2} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service JAN - 5 2005 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Tina Dreiling Associate Regulatory Affairs Specialist Medtronic Surgical Navigation Technologies 826 Coal Creek Circle Louisville, Colorado 80027 Re: K043088 Trade/Device Name: Medtronic (SNT) StealthStation AxiEM™ Imageless Knee Module Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: II Product Code: HAW Dated: November 4, 2004 Received: November 8, 2004 Dear Ms. Dreiling: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA’s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3} Page 2 - Ms. Tina Dreiling This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Miriam C. Provost of Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4} Medtronic (SNT) StealthStation AxiEM™ Imageless Knee Module 510(k) Number (if known): K043088 Device Name: Medtronic (SNT) StealthStation AxiEM™ Imageless Knee Module ## Indications for Use: The indications for use are as follows: The StealthStation® System is intended as an aid for precisely locating anatomical structures in either open or percutaneous procedures. The StealthStation® System is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT or MR based model, fluoroscopy images, or digitized landmarks of the anatomy. Example procedures include, but are not limited to: - **Cranial Procedures:** - Cranial Biopsies - Tumor Resections - Craniotomies/ Craniectomies - Skull Base procedures - Thalamotomies/Pallidotomies - Pituitary Tumor Removal - CSF Leak Repair - Pediatric Catheter Shunt Placement - General Catheter Shunt Placement - **Spinal Procedures:** - Spinal Implant Procedures, such as Pedicle Screw Placement - **ENT Procedures:** - Transphenoidal Procedures - Intranasal Procedures - Orbital Nerve Decompression Procedures - Optic Nerve Decompression Procedures - Polyposis Procedures - Endoscopic Dacryocystorhinostomy - Encephalocele Procedures - Sinus procedures, such as Maxillary Antrostomies, Ethmoidectomies, Sphenoidotomies/Sphenoid Explorations, Turbinate Resections, and Frontal Sinusotomies - Orthopaedic Procedures: - Total Knee Arthroplasty (Primary and Revision) - Unicompartmental Knee Arthroplasty - Minimally Invasive Orthopaedic Knee Procedures Prescription Use ☑ (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use ☐ (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) *Muriam C. Provost* (Division Sign-Off) Division of General, Restorative, and Neurological Devices 510(k) Number K043088 Medtronic Surgical Navigation Technologies --- **Source:** [https://fda.innolitics.com/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/HAW/K043088](https://fda.innolitics.com/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/HAW/K043088) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com